Skip to content

A prospective randomised controlled trial investigating three dimensional knee joint kinematics in total knee replacement – a comparison of cruciate retaining, posterior cruciate sacrificing and medially stabilised designs.

A prospective randomised controlled trial investigating three dimensional knee joint kinematics in patients with osteoarthritis undergoing total knee replacement – a comparison of cruciate retaining, posterior cruciate sacrificing and medially stabilised designs.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613001278729
Acronym
Medacta knee kinematics
Enrollment
90
Registered
2013-11-19
Start date
2014-07-01
Completion date
2016-10-06
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is an investigator initiated study, aiming to assess the prosthetic performance of total knee replacements (TKR) and to determine whether abnormal movement of the replaced knee has an impact upon function and pain at one year post-operatively. By using a prospective analysis of patients randomized to receive TKR of different designs, this study aims to determine the effect the type of prosthesis has on gait, three-dimensional joint movement plus both clinical and patient reported outcomes. In order to achieve this, joint motion, ground reaction forces and muscle activity will be recorded simultaneously from each subject during four test conditions; level walking, stair ascent, stair descent and chair rise. Limb alignment, pain and functional assessments will also be evaluated, to assist in determining variables associated with improved functional outcomes following TKR.

Interventions

All participants in this trial will receive a total knee replacement. The prosthesis used will be the GMK Total Prosthesis from Medacta International SA. Randomisation will allocate patients to have one of three different types of prosthesis from this suite of prostheses. These are (1) posterior cruciate ligament retaining prosthesis, (2) a posterior cruciate ligament sacrificing/subsituting prosthesis and (3) a medially stabilised prosthesis - the GMK Sphere. The key differences between the

All participants in this trial will receive a total knee replacement. The prosthesis used will be the GMK Total Prosthesis from Medacta International SA. Randomisation will allocate patients to have one of three different types of prosthesis from this suite of prostheses. These are (1) posterior cruciate ligament retaining prosthesis, (2) a posterior cruciate ligament sacrificing/subsituting prosthesis and (3) a medially stabilised prosthesis - the GMK Sphere. The key differences between these prostheses is the level of antero-posterior constraint and the way in which the posterior cruciate ligament is handled. The approximate duration for knee replacement surgery is 90 minutes, the standard operative time for all elective knee replacement surgery, regardless of the device being utilised.

Sponsors

Professor Peter Choong
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

i) on the waiting list for primary total knee replacement due to osteoarthritis at St Vincent's Hospital, Melbourne ii) knee replacement performed by one of three joint replacement surgeons at St Vincent's Hospital whose prosthesis of choice is the Medacta GMK Knee System

Exclusion criteria

i) Surgery for neoplastic disease ii) Inability to provide informed consent

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026